This section features information on all TRANSCAN funded projects by country and funding organization. Click on a country/funding organization to find out what projects have been financed by a specific country/funding organization.
Integration of genetic biomarkers and early minimal residual disease to improve risk stratification and cure in childhood Acute Lymphoblastic Leukemia
Cancer evolution and identification of relapse-initiating cells
Fighting Resistance in CLL
Multiple myeloma intra-clonal heterogeneity: evolution and implications of targeted therapy
Proteogenomic and targeted metabolomic analysis of ovarian cancer heterogeneity and its contribution to recurrence and therapy resistance
A randomized, 2x2 biomarker prevention trial of low-dose aspirin and metformin in colon cancer patients
Exploiting the peptidome of atypical teratoid/rhabdoid tumors - characterization of novel tumor-associated antigens for immunotherapy in order to maintain long-term remissions
MicroRNAs methylation and expression profiling for identification of breast cancer patients at high risk to develop distant metastases
New technologies for early detection of HLA loss leukemia relapse after allogeneic hematopoietic stem cell transplantation, and identification of relevant risk factors
Identification of molecular therapeutic targets and diagnostic/prognostic biomarkers for Malignant Transformation of Osteochondromas
Mesalamine for Colorectal Cancer Prevention Program in Lynch syndrome
Personalized prevention of colorectal neoplasia by use of genetic variability for the prediction of efficacy and toxicity of treatment with COX-2 inhibitors and aspirin
Validation of the impact of genetic aberrations and host genetic variation in childhood acute lymphoblastic leukemia for integration into clinical practice
Prediction of Nivolumab action in metastatic renal cancer patients: Treg function, tumoral access and NK interaction as predictive biomarkers of immunotherapy
Invigorating immunity against brain metastases in lung and breast cancer patients
Reverting immune suppression to elicit brain metastasis control
Artificial-intelligence-based end-to-end prediction of cancer immunotherapy response
Innovative mRNA vaccine against NSCLC: Designing a platform of targeted polymeric nanoparticles for efficient personalized therapy
Innovative peptide- and RNA-based strategies to modulate p53 for pancreatic cancer therapy
Systemic IMMunological determinants of tumor evolution and therapy response in BRCA-mutated pancreatic cancer
Sarcoma subtyping and stratification using genome-wide epigenetic profiling
Exploring the epigenetic neuroblastoma landscape to improve measurable disease monitoring, disease understanding and personalized treatment
Deciphering Epigenetic Biomarkers to Identify Preleukemic Carriers at Risk
Subscribe to our Newsletter You can unsubscribe at any moment by clicking on the subscription preferences link at the bottom of a received newsletter.
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No. 964264.
Legal Notice | Privacy Policy